• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SARS-CoV-2 将继续在人群中传播:从病毒与宿主关系的角度看。

SARS-CoV-2 will continue to circulate in the human population: an opinion from the point of view of the virus-host relationship.

机构信息

V.I. Vernadsky Crimean Federal University, Simferopol, Russia.

出版信息

Inflamm Res. 2020 Jul;69(7):635-640. doi: 10.1007/s00011-020-01352-y. Epub 2020 Apr 30.

DOI:10.1007/s00011-020-01352-y
PMID:32350571
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7190393/
Abstract

At the population level, the virus-host relationship is not set up to end with the complete elimination of either or both. Pathogen-resistant individuals will always remain in the host population. In turn, the virus can never completely eliminate the host population, because evolutionarily such an event is a dead end for the virus as an obligate intracellular parasite. A certain existential balance exists in the virus-host relationship. Against this backdrop, viral epidemics and pandemics only become manifest and egregious to human beings when tens and hundreds of thousands of people die and the question emerges what caused the high mortality peaks on the death chart. The answer seems clear; the emerging strain of the virus is new to the host population, and new mutations of the virus and natural selection will lead to a survival of only genetically resistant individuals in a host population. The dangers inherent to a novel virus are due to new features generally inthe molecular structure of proteins, which enable the virus to infect the cells of the host organism more intensively, dramatically challenging host immunity, and thus be transmitted more readily in the host population. In this article, we will concentrate on the facts currently available about severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has caused COVID-19 (coronavirus disease 2019) pandemic and try to predict its development and consequences based on the virus-host relationship. In fact, only two scenarios will occur simultaneously in the very near future: people who are genetically resistant to the virus will get sick, recover, and develop immunity, while people who are sensitive to the virus will need drugs and vaccines, which will have to be researched and developed if they are to recover. If the pandemic does not stop, in a few decades it is anticipated that SARS-CoV-2 will become as safe as the four non-severe acute respiratory syndrome human coronaviruses (HCoV-NL63, HCoV-HKU1, HCoV-OC43, and HCoV-229E) currently circulating but causing low mortality in the human population.

摘要

从群体水平看,病毒与宿主之间的关系不会以一方或双方的完全消灭而告终。具有病原体抗性的个体将始终存在于宿主群体中。反过来,病毒也永远无法完全消灭宿主群体,因为从进化角度来看,对于作为专性细胞内寄生虫的病毒来说,这种情况是死胡同。病毒与宿主之间存在某种生存平衡。在这种背景下,只有当数以万计的人死亡,并且出现了导致死亡图表上高死亡率峰值的原因这个问题时,病毒的流行和大流行才会对人类产生明显和严重的影响。答案似乎很明确;宿主群体中出现的新病毒株对宿主是全新的,病毒的新突变和自然选择将导致宿主群体中只有具有遗传抗性的个体存活下来。新型病毒所带来的危险源于蛋白质分子结构中的新特征,这些特征使病毒能够更强烈地感染宿主细胞,对宿主免疫产生巨大挑战,从而更容易在宿主群体中传播。在本文中,我们将集中讨论目前关于严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)的事实,该病毒引发了 COVID-19(2019 年冠状病毒病)大流行,并试图根据病毒与宿主的关系预测其发展和后果。事实上,在不久的将来,只有两种情况会同时发生:具有病毒遗传抗性的人会生病、康复并产生免疫力,而对病毒敏感的人则需要药物和疫苗,如果要康复,就必须研究和开发这些药物和疫苗。如果大流行不停止,预计在几十年内,SARS-CoV-2 将变得像目前在人群中传播但死亡率较低的四种非严重急性呼吸综合征人类冠状病毒(HCoV-NL63、HCoV-HKU1、HCoV-OC43 和 HCoV-229E)一样安全。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66fe/7190393/529fbbb54d70/11_2020_1352_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66fe/7190393/529fbbb54d70/11_2020_1352_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66fe/7190393/529fbbb54d70/11_2020_1352_Fig1_HTML.jpg

相似文献

1
SARS-CoV-2 will continue to circulate in the human population: an opinion from the point of view of the virus-host relationship.SARS-CoV-2 将继续在人群中传播:从病毒与宿主关系的角度看。
Inflamm Res. 2020 Jul;69(7):635-640. doi: 10.1007/s00011-020-01352-y. Epub 2020 Apr 30.
2
Overview of lethal human coronaviruses.致死性人类冠状病毒概述。
Signal Transduct Target Ther. 2020 Jun 10;5(1):89. doi: 10.1038/s41392-020-0190-2.
3
Why COVID-19 Transmission Is More Efficient and Aggressive Than Viral Transmission in Previous Coronavirus Epidemics?为何 COVID-19 的传播效率和攻击性比以往冠状病毒疫情中的病毒传播更高?
Biomolecules. 2020 Sep 11;10(9):1312. doi: 10.3390/biom10091312.
4
COVID-19 Vaccine: A comprehensive status report.新型冠状病毒肺炎疫苗:全面现状报告。
Virus Res. 2020 Oct 15;288:198114. doi: 10.1016/j.virusres.2020.198114. Epub 2020 Aug 13.
5
The 2020 Pandemic: Current SARS-CoV-2 Vaccine Development.2020 年大流行:当前 SARS-CoV-2 疫苗的开发。
Front Immunol. 2020 Aug 19;11:1880. doi: 10.3389/fimmu.2020.01880. eCollection 2020.
6
Natural Flavonoids as Potential Angiotensin-Converting Enzyme 2 Inhibitors for Anti-SARS-CoV-2.天然类黄酮作为潜在的血管紧张素转换酶 2 抑制剂用于抗 SARS-CoV-2。
Molecules. 2020 Sep 1;25(17):3980. doi: 10.3390/molecules25173980.
7
Coronaviruses and SARS-COV-2.冠状病毒和 SARS-COV-2。
Turk J Med Sci. 2020 Apr 21;50(SI-1):549-556. doi: 10.3906/sag-2004-127.
8
Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Binding to ACE2 Receptors from Human, Pets, Farm Animals, and Putative Intermediate Hosts.严重急性呼吸综合征冠状病毒 2 刺突蛋白与人、宠物、农场动物和潜在中间宿主 ACE2 受体结合的比较。
J Virol. 2020 Jul 16;94(15). doi: 10.1128/JVI.00831-20.
9
SARS-CoV-2 will constantly sweep its tracks: a vaccine containing CpG motifs in 'lasso' for the multi-faced virus.SARS-CoV-2 将不断扫荡其踪迹:一种含有 CpG 基序的“套索”疫苗,针对多面病毒。
Inflamm Res. 2020 Sep;69(9):801-812. doi: 10.1007/s00011-020-01377-3. Epub 2020 Jul 12.
10
COVID-19 Coronavirus spike protein analysis for synthetic vaccines, a peptidomimetic antagonist, and therapeutic drugs, and analysis of a proposed achilles' heel conserved region to minimize probability of escape mutations and drug resistance.用于合成疫苗、肽模拟拮抗剂和治疗性药物的 COVID-19 冠状病毒刺突蛋白分析,以及对保守区域阿喀琉斯之踵的分析,以最大程度地降低逃逸突变和耐药性的可能性。
Comput Biol Med. 2020 Jun;121:103749. doi: 10.1016/j.compbiomed.2020.103749. Epub 2020 Apr 11.

引用本文的文献

1
Breakthrough Infection and Death after COVID-19 Vaccination: A Physics Perspective.新冠疫苗接种后的突破性感染与死亡:物理学视角
J Biomed Phys Eng. 2025 Jun 1;15(3):299-306. doi: 10.31661/jbpe.v0i0.2212-1577. eCollection 2025 Jun.
2
The Ability of Combined Flavonol and Trihydroxyorganic Acid to Suppress SARS-CoV-2 Reproduction.黄酮醇与三羟基有机酸联合抑制新型冠状病毒复制的能力
Viruses. 2024 Dec 30;17(1):37. doi: 10.3390/v17010037.
3
Characteristics of lymphocyte subset alterations in COVID-19 patients with different levels of disease severity.

本文引用的文献

1
On the origin and continuing evolution of SARS-CoV-2.关于严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的起源及持续进化
Natl Sci Rev. 2020 Jun;7(6):1012-1023. doi: 10.1093/nsr/nwaa036. Epub 2020 Mar 3.
2
Probable Pangolin Origin of SARS-CoV-2 Associated with the COVID-19 Outbreak.与COVID-19疫情相关的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)可能起源于穿山甲。
Curr Biol. 2020 Apr 20;30(8):1578. doi: 10.1016/j.cub.2020.03.063.
3
The proximal origin of SARS-CoV-2.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的近端起源。
淋巴细胞亚群改变特征与不同严重程度 COVID-19 患者。
Virol J. 2022 Nov 19;19(1):192. doi: 10.1186/s12985-022-01926-8.
4
Coming Out of Nowhere: The Paradox of the Birth of Omicron.凭空出现:奥密克戎毒株诞生的悖论。
J Biomed Phys Eng. 2022 Aug 1;12(4):325-326. doi: 10.31661/jbpe.v0i0.2202-1456. eCollection 2022 Aug.
5
Epidemiology, Clinico-Pathological Characteristics, and Comorbidities of SARS-CoV-2-Infected Pakistani Patients.新型冠状病毒感染的巴基斯坦患者的流行病学、临床病理特征和合并症。
Front Cell Infect Microbiol. 2022 May 26;12:800511. doi: 10.3389/fcimb.2022.800511. eCollection 2022.
6
The role of IL-1 family of cytokines and receptors in pathogenesis of COVID-19.IL-1 家族细胞因子及其受体在 COVID-19 发病机制中的作用。
Inflamm Res. 2022 Aug;71(7-8):923-947. doi: 10.1007/s00011-022-01596-w. Epub 2022 Jun 25.
7
Swine coronaviruses (SCoVs) and their emerging threats to swine population, inter-species transmission, exploring the susceptibility of pigs for SARS-CoV-2 and zoonotic concerns.猪冠状病毒 (SCoVs) 及其对猪群的新兴威胁、种间传播、探索猪对 SARS-CoV-2 的易感性和人畜共患问题。
Vet Q. 2022 Dec;42(1):125-147. doi: 10.1080/01652176.2022.2079756.
8
How immunity from and interaction with seasonal coronaviruses can shape SARS-CoV-2 epidemiology.季节性冠状病毒带来的免疫和相互作用如何塑造 SARS-CoV-2 的流行病学。
Proc Natl Acad Sci U S A. 2021 Dec 7;118(49). doi: 10.1073/pnas.2108395118.
9
Epidemiological Characteristics of Infectious Diseases Among Travelers Between China and Foreign Countries Before and During the Early Stage of the COVID-19 Pandemic.《新冠疫情大流行前及初期中国出入境旅行者传染病流行病学特征》。
Front Public Health. 2021 Nov 3;9:739828. doi: 10.3389/fpubh.2021.739828. eCollection 2021.
10
SARS-COV-2 vaccine: first-month results of a six-month follow-up study.SARS-CoV-2 疫苗:一项为期 6 个月随访研究的首月结果。
Turk J Med Sci. 2022 Feb;52(1):21-31. doi: 10.3906/sag-2106-63. Epub 2022 Feb 22.
Nat Med. 2020 Apr;26(4):450-452. doi: 10.1038/s41591-020-0820-9.
4
Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection.单细胞 RNA 测序数据分析受体 ACE2 的表达揭示了不同人体器官易感染 2019-nCoV 的潜在风险。
Front Med. 2020 Apr;14(2):185-192. doi: 10.1007/s11684-020-0754-0. Epub 2020 Mar 12.
5
Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic.COVID-19 的免疫反应和潜在疫苗:从 SARS 和 MERS 疫情中吸取的教训。
Asian Pac J Allergy Immunol. 2020 Mar;38(1):1-9. doi: 10.12932/AP-200220-0772.
6
No credible evidence supporting claims of the laboratory engineering of SARS-CoV-2.没有可信证据支持新冠病毒是通过实验室工程制造的说法。
Emerg Microbes Infect. 2020 Feb 26;9(1):505-507. doi: 10.1080/22221751.2020.1733440. eCollection 2020.
7
A new coronavirus associated with human respiratory disease in China.一种在中国与人类呼吸道疾病相关的新型冠状病毒。
Nature. 2020 Mar;579(7798):265-269. doi: 10.1038/s41586-020-2008-3. Epub 2020 Feb 3.
8
Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission.新型冠状病毒在武汉持续爆发中的进化及其刺突蛋白对人类传播风险的建模。
Sci China Life Sci. 2020 Mar;63(3):457-460. doi: 10.1007/s11427-020-1637-5. Epub 2020 Jan 21.
9
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.新冠病毒的基因组特征和流行病学:对病毒起源和受体结合的影响。
Lancet. 2020 Feb 22;395(10224):565-574. doi: 10.1016/S0140-6736(20)30251-8. Epub 2020 Jan 30.
10
Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany.德国一名无症状接触者传播2019新型冠状病毒感染
N Engl J Med. 2020 Mar 5;382(10):970-971. doi: 10.1056/NEJMc2001468. Epub 2020 Jan 30.